FDA Investigator Marcia G Evans
Marcia G Evans has conducted inspections on 47 sites in 1 countries as of 28 Sep 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
47
Last Inspection Date:
28 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Marcia G Evans:
Adam C Hipko,
Akbar J Zaidi,
Alantis N Griffin,
Alexis O Robinson,
Andrew J Lang,
Anetra E Wyatt,
Ashley N Williams,
Brandi E Williams,
Carol A Declouette Wilburn,
Charles B Steinmiller,
Charles D Brown,
Charles E Shaffer,
Charles N Dupont,
Christine I Shaw,
Christopher L Jacobs,
Christopher N Dedeaux,
Claire M Minden,
Connie L Hannon Rabel,
Cynthia A Harris, MD, RN,
Daniel J Lahar,
David M Beltran,
David R Heiar,
Diane S Douglas,
Ellen J Tave,
Gilbert Valdez, RS,
Grant L Davis,
Herman S Clincy,
J Elkins,
Jacey Roy,
Jacob W Reynolds,
James R Montero,
Janet B Abt,
Janete F Guardia,
Jennifer O Dowdy,
Jenny L Chisem,
Jenny L Mccardell,
Jocelyn C Turner,
Johnson,
Jonaida Estevez Martinez,
Jonathan A Womack,
Juan D Lopez,
Karlton T Watson,
Kathleen Chmura Shaffer,
Kenitra D Hewitt,
Larry A Estavan,
Lauren E Skokan,
Leighton Kn Gai,
Linda Linh N Adams,
Lisa A Warner,
Lisa R Whitt,
Llopis,
Lorenzo Jones,
Mahaffey,
Maida Henesian (NMI),
Marcus A Green,
Margaret E Slimbach,
Michael L Jones,
Olalere D Fasipe,
Patrick C Dooley,
Pauline N Logan,
Phillip M Pontikos,
Regina D Hunt,
Rendall E Barfoot,
Robert T Harris,
Roy Baby,
Samuel L Collins,
Sandricka M Mosley,
Sandy L Atkins,
Scott A Watson,
Scott T Ballard,
Selina M Mata,
Sherrie L Krolczyk,
Staci G Mcallister,
Tamera H Hunt,
Terri E Gibson,
Thomas Martinez,
Trina K Vick,
Tuan A Nguyen,
Verlinda A Narcisse,
Wanda B Coats,
Wayne S Fortenberry,
Yaw O Osei
Marcia G Evans's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2019 | FDA 483 | Curewave Lasers LLC - Form 483, 2019-09-05 |
January, 2020 | FDA 483 | Venus Concept Inc - Form 483, 2020-01-16 |
February, 2019 | FDA 483 Response | NEW LIFE DIAGNOSTICS LLC - Form 483R, 2019-02-27 |
February, 2019 | FDA 483 | NEW LIFE DIAGNOSTICS LLC - Form 483, 2019-02-27 |
March, 2020 | EIR | Nurse Assist, LLC - EIR, 2020-03-23 |
February, 2019 | EIR | NEW LIFE DIAGNOSTICS LLC - EIR, 2019-03-20 |
June, 2019 | FDA 483 | Matia Robotics US, Inc. - Form 483, 2019-06-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more